Suppr超能文献

通过具有自动DNA制备功能的内控实时PCR检测法对致病性炭疽芽孢杆菌的孢子和营养体形式进行高通量筛选。

High throughput screening for spores and vegetative forms of pathogenic B. anthracis by an internally controlled real-time PCR assay with automated DNA preparation.

作者信息

Panning Marcus, Kramme Stefanie, Petersen Nadine, Drosten Christian

机构信息

Clinical Virology Group, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht Str. 74, 20359 Hamburg, Germany.

出版信息

Med Microbiol Immunol. 2007 Mar;196(1):41-50. doi: 10.1007/s00430-006-0029-7. Epub 2006 Nov 9.

Abstract

Human infections with Bacillus anthracis have become rare but in cases of intentional release, masses of samples would have to be expected. Current PCR assays for anthrax are appropriate for use in single cases, but they have not been formulated for high throughput screening. This article describes a high throughput real-time PCR for anthrax, including automated sample preparation without the need for pre-culturing of samples. The assay detects single copies of target gene. An internal control monitors the whole assay including sample preparation. The limit of detection in blood was 1,066 (95%CI, 741-1,739) copies/ml, corresponding to 4.4-32.3 organisms/ml. Using spore preparations, 20 colony-forming units (CFU) per sample could be detected reliably (0.8 CFU per PCR). The extraction procedures depleted viable spores from solution by factors of 10,000 (automated procedure) and >100,000 (conventional column procedure). One hundred and ten clinical and environmental specimens were retested, 50 of them sampled during a period of heightened anthrax awareness in 2001. A widely used assay yielded two false positive results (cross-reaction with B. cereus), while the new assay tested all samples negative. The internal control operated stable in all clinical samples. The assay is capable of testing for anthrax in the high throughput mode.

摘要

人类感染炭疽芽孢杆菌的情况已较为罕见,但在故意释放的情况下,预计会出现大量样本。目前用于炭疽检测的聚合酶链反应(PCR)检测方法适用于单个病例,但尚未针对高通量筛查进行设计。本文描述了一种用于炭疽检测的高通量实时PCR方法,包括无需对样本进行预培养的自动化样本制备。该检测方法可检测目标基因的单拷贝。一个内部对照可监测整个检测过程,包括样本制备。血液中的检测限为1,066(95%可信区间,741 - 1,739)拷贝/毫升,相当于4.4 - 32.3个菌体/毫升。使用芽孢制剂时,每个样本可可靠检测到20个菌落形成单位(CFU)(每个PCR为0.8 CFU)。提取程序可使溶液中的活芽孢数量减少10,000倍(自动化程序)和超过100,000倍(传统柱式程序)。对110份临床和环境标本进行了重新检测,其中50份是在2001年炭疽关注度提高期间采集的。一种广泛使用的检测方法产生了两个假阳性结果(与蜡样芽孢杆菌交叉反应),而新检测方法检测所有样本均为阴性。内部对照在所有临床样本中运行稳定。该检测方法能够以高通量模式检测炭疽。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验